177 related articles for article (PubMed ID: 27061114)
1. A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.
Fairclough M; Prenant C; Ellis B; Boutin H; McMahon A; Brown G; Locatelli P; Jones AK
J Labelled Comp Radiopharm; 2016 Jun; 59(7):270-6. PubMed ID: 27061114
[TBL] [Abstract][Full Text] [Related]
2. Development of a method for the preparation of zirconium-89 radiolabelled chitosan nanoparticles as an application for leukocyte trafficking with positron emission tomography.
Fairclough M; Ellis B; Boutin H; Jones AKP; McMahon A; Alzabin S; Gennari A; Prenant C
Appl Radiat Isot; 2017 Dec; 130():7-12. PubMed ID: 28923298
[TBL] [Abstract][Full Text] [Related]
3. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
4.
Kahts M; Guo H; Kommidi H; Yang Y; Sayman HB; Summers B; Ting R; Zeevaart JR; Sathekge M; Aras O
EJNMMI Radiopharm Chem; 2023 Nov; 8(1):36. PubMed ID: 37930454
[TBL] [Abstract][Full Text] [Related]
5. A kit formulation for the preparation of [
Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
[TBL] [Abstract][Full Text] [Related]
6. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
8. Phase I/IIa PET imaging study with
Joraku A; Hatano K; Kawai K; Kandori S; Kojima T; Fukumitsu N; Isobe T; Mori Y; Sakata M; Hara T; Nasu K; Minami M; Iizumi Y; Nishiyama H
Ann Nucl Med; 2019 Feb; 33(2):119-127. PubMed ID: 30406361
[TBL] [Abstract][Full Text] [Related]
9.
Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different
Bansal A; Sharma S; Klasen B; Rösch F; Pandey MK
Sci Rep; 2022 Sep; 12(1):15646. PubMed ID: 36123386
[TBL] [Abstract][Full Text] [Related]
11. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
[TBL] [Abstract][Full Text] [Related]
12. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging.
Shi S; Fliss BC; Gu Z; Zhu Y; Hong H; Valdovinos HF; Hernandez R; Goel S; Luo H; Chen F; Barnhart TE; Nickles RJ; Xu ZP; Cai W
Sci Rep; 2015 Nov; 5():16930. PubMed ID: 26585551
[TBL] [Abstract][Full Text] [Related]
13. Imaging of cell-based therapy using
Kurebayashi Y; Choyke PL; Sato N
Nanotheranostics; 2021; 5(1):27-35. PubMed ID: 33391973
[TBL] [Abstract][Full Text] [Related]
14. In vitro human leukocyte labeling with (64)Cu: an intraindividual comparison with (111)In-oxine and (18)F-FDG.
Bhargava KK; Gupta RK; Nichols KJ; Palestro CJ
Nucl Med Biol; 2009 Jul; 36(5):545-9. PubMed ID: 19520295
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.
Seo JW; Mahakian LM; Tam S; Qin S; Ingham ES; Meares CF; Ferrara KW
Nucl Med Biol; 2015 Feb; 42(2):155-63. PubMed ID: 25451215
[TBL] [Abstract][Full Text] [Related]
16. Semi-automated production of ⁸⁹Zr-oxalate/⁸⁹Zr-chloride and the potential of ⁸⁹Zr-chloride in radiopharmaceutical compounding.
Lin M; Mukhopadhyay U; Waligorski GJ; Balatoni JA; González-Lepera C
Appl Radiat Isot; 2016 Jan; 107():317-322. PubMed ID: 26595775
[TBL] [Abstract][Full Text] [Related]
17. A Distinct Advantage to Intraarterial Delivery of
Lesniak WG; Chu C; Jablonska A; Du Y; Pomper MG; Walczak P; Janowski M
J Nucl Med; 2019 May; 60(5):617-622. PubMed ID: 30315146
[TBL] [Abstract][Full Text] [Related]
18. Total-Body PET and Highly Stable Chelators Together Enable Meaningful
Berg E; Gill H; Marik J; Ogasawara A; Williams S; van Dongen G; Vugts D; Cherry SR; Tarantal AF
J Nucl Med; 2020 Mar; 61(3):453-460. PubMed ID: 31562219
[TBL] [Abstract][Full Text] [Related]
19. Light-Induced Radiosynthesis of
Klingler S; Fay R; Holland JP
J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Zirconium-89 Chelator Development.
Bhatt NB; Pandya DN; Wadas TJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29534538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
